We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Prir is a new premium functional soft drink that not only provides a great tasting, healthier way to hydrate but also gives you the valuable nutrition you need to help maintain healthy skin, hair and nails. Prir is currently stocked in over 300 Boots stores nationwide and is also available in the boots meal deal.
days to go: Expired investment: £12,770
Opened in 2014, The Lakes Distillery has sold over 160,000 bottles of their premium gin, vodka, and blended whisky; voted one of the top 5 best new distilleries in the world.
days to go: Expired investment: £1,620,110
Vita Mojo is an award winning food technology company, providing affordable meals tailored specifically to the customer. The food is personal and transparent as to what goes into each dish and how it was prepared. All ingredients are picked to suit your own tastes and needs, and can be personalised to increase your protein or decrease your calories as required. 
days to go: Expired investment: £3,200,080
An award-wining organic snack and baking company focusing on allergy-free foods that only contain natural sugars and are suitable for vegans. Creative Nature's products are available in more than 3,500 stores in the UK, as well as online and worldwide in 11 countries. Over the next 12 months, the business intends to provide an online subscription model to generate greater website revenue and to increase production across their product range.
days to go: Expired investment: £503,232
Equal Health's (EH) mission is to create a healthy organic food brand that makes a difference to the environment and its customers' health. The company wants to become the go-to brand for healthy organic meals. EH uses seasonal organic ingredients which are ethically sourced, cooked and packed in its kitchen by its expert team of chefs. It received its organic status through the UK's leading certification body, The Soil Association. It aims to launch a new range of healthy organic frozen meals. EH will use the investment to focus on digital marketing, increase its kitchen facilities, and invest in New Product Development (NPD).

Pitch Rated

43%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £226,598
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph